- Certain types of advanced thyroid cancer
- Advanced Liver cancer
- Certain types of kidney cancer
- Endometrial cancer

LENTA 4MG
| MRP | : |
|
| Price | : | ₹1,000.00 |
| You Save | : | ₹264.69 (20.93%) |
10 Capsule(s) In A Strip
Lenta 4mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor that is prescribed for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is utilized for treating liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.
Anaplastic Thyroid Carcinoma, a form of advanced thyroid cancer, typically manifests in individuals over the age of 60. Symptoms include an enlarged and hardened thyroid gland, along with hoarseness resulting from nerve paralysis in the voice box.
Hepatocellular carcinoma, or liver cancer, often arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals who have experienced an allergic reaction to Lenta 4mg Capsule or any of its ingredients should avoid using this medication. Furthermore, patients must notify their dentist or oral surgeon about their use of Lenta 4mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.